Here are relevant reports on : lab-grown-diamond-market
-
Healthcare Interoperability Solutions Market by Type (Software (EHR, Lab System, Imaging, Health Information Exchange, Enterprises), and Services), Interoperability Level (Foundational, Structural, Semantic), End User, and Region - Global Forecast to 2027
The global Healthcare interoperability solutions market, valued at US$3.0 billion in 2021, stood at US$3.4 billion in 2022 and is projected to advance at a resilient CAGR of 12.9% from 2022 to 2027, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is driven by the government funding to increase adption of healthcare interoperability solutions, and the emergence of new technologies.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030
The global biochips market, valued at US$12,907.5 million in 2024, stood at US$14,011.6 million in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2030, culminating in a forecasted valuation of US$21,356.4 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Mercury Analyzer Market by Type (Cold Vapor Atomic Absorption and Cold Vapor Atomic Fluorescence), Monitoring Type (Continuous and Lab), End-Use Industry (Environmental Monitoring, Food Industry) and Region - Global Forecast to 2029
The mercury analyzer market is expected to grow from USD 310 million in 2024 to USD 426 million by 2029, at a compound annual growth rate (CAGR) of 6.6% during the forecast period.The key players Teledyne Leeman Labs (US), Tekran Instruments Corporation (Canada), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), Milestone Srl (US), Analytik Jena GmbH+Co. KG (Germany), Nippon Instruments Corporation (Japan), Hitachi High-Tech Corporation (Japan), Lumex Instruments (Canada), ENVEA (France).
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Clinical Trial Services Market by Type (Lab, Monitoring, Contracts, Recruitment, PV, Biostatistics), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global forecast to 2031
The global clinical trial services market is projected to reach USD 97.41 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020
The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020. Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market.
- Published: February 2016
- Price: $ 4950
- TOC Available:
-
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) - Global Forecasts to 2022
The protein assays market is projected to reach USD 2.41 Billion by 2022, at a CAGR of 11.1%. Some of the prominent players in the market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Lab Accessories Market by Type (Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & Pharmaceutical Companies/Hospital/Private Labs/Research Institute) - Global Forecast to 2020
The laboratory accessories market is valued at $327.0 million in 2014. It is expected to reach $504.7 million by 2020, growing at a CAGR of 7.5% from 2014 to 2020. The laboratory accessories market is dominated by North America, it is followed by Europe, Asia and Rest of the world. The Asian market is the fastest growing in the forecast period (2014-2020). Reagent reservoirs is the fastest-growing segment of this market.
- Published: March 2015
- Price: $ 4950
- TOC Available:
-
Clinical Communication & Collaboration Market By Platform (Voice, Messaging), Component (Badge, Nurse Call, VOIP, Wearable, Alert, Scheduling, Telehealth), Application (Nurse, Lab/Radiology, Patient), End User (Hospitals, ASC) - Global Forecast to 2030
The global clinical communication & collaboration market, valued at US$2,598.1 million in 2024, stood at US$2,876.1 million in 2025 and is projected to advance at a resilient CAGR of 13.02% from 2025 to 2030, culminating in a forecasted valuation of US$5,302.9 million by the end of the period. The clinical communication and collaboration market is experiencing rapid growth, driven by the increasing need for real-time communication and effective care coordination.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
The global molecular quality controls market, valued at US$0.2 billion in 2022, stood at US$0.2 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The growth of this market is primarily driven by the increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, and increasing government funding for genomic projects.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
